| Dr Matthew A Vail, MD | |
|
3545 Olentangy River Rd, Suite 425, Columbus, OH 43214-3907 | |
| (614) 566-5335 | |
| (614) 566-6931 |
| Full Name | Dr Matthew A Vail |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 3545 Olentangy River Rd, Columbus, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336299932 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 78651 (Ohio) | Primary |
| Entity Name | Ohiohealth Employer Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598289217 PECOS PAC ID: 2466727318 Enrollment ID: O20171003007712 |
News Archive
DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC, for the third quarter of fiscal 2011, ended October 1, 2011.
Varian, Inc. announced today that Bruker Corporation and Agilent Technologies, Inc. have entered into a definitive asset purchase agreement pursuant to which Bruker will acquire certain product lines of Varian. As previously announced, Agilent committed to divest those product lines in connection with obtaining regulatory approval for Agilent's pending acquisition of Varian.
The respective microRNA seed region influences the production of sensory hair cells in the inner ear, both in the mouse and in humans.
An acceleration in obesity among young teenagers could be explained by a 12-year-long study which found that the number of calories they burn while at rest drops suddenly in puberty.
There's a new treatment option available for patients with AL amyloidosis: daratumumab. Studied in a prospective clinical trial, only one of the two clinical trials of this agent in AL amyloidosis worldwide, researchers have found this anti-cancer drug to be well tolerated and effective in patients with relapsed AL amyloidosis when used with appropriate pre- and post-infusion medications.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew A Vail, MD 3545 Olentangy River Rd, Suite 425, Columbus, OH 43214-3907 Ph: (614) 566-5335 | Dr Matthew A Vail, MD 3545 Olentangy River Rd, Suite 425, Columbus, OH 43214-3907 Ph: (614) 566-5335 |
News Archive
DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC, for the third quarter of fiscal 2011, ended October 1, 2011.
Varian, Inc. announced today that Bruker Corporation and Agilent Technologies, Inc. have entered into a definitive asset purchase agreement pursuant to which Bruker will acquire certain product lines of Varian. As previously announced, Agilent committed to divest those product lines in connection with obtaining regulatory approval for Agilent's pending acquisition of Varian.
The respective microRNA seed region influences the production of sensory hair cells in the inner ear, both in the mouse and in humans.
An acceleration in obesity among young teenagers could be explained by a 12-year-long study which found that the number of calories they burn while at rest drops suddenly in puberty.
There's a new treatment option available for patients with AL amyloidosis: daratumumab. Studied in a prospective clinical trial, only one of the two clinical trials of this agent in AL amyloidosis worldwide, researchers have found this anti-cancer drug to be well tolerated and effective in patients with relapsed AL amyloidosis when used with appropriate pre- and post-infusion medications.
› Verified 1 days ago
Eric Andrew Schaub, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 1492 East Broad Street, Columbus, OH 43205 Phone: 614-257-3559 Fax: 614-257-2450 | |
Dr. Patrick Ryan Mckenna, D.O. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 700 Childrens Dr # A1034, Columbus, OH 43205 Phone: 614-355-4135 | |
Teresa Charl Long, M.D., M.P.H. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 240 Parsons Ave, Columbus, OH 43215 Phone: 614-645-7417 | |
Christopher Jacob Devlin, ATC Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 8332 Seattle Ave Apt 10112, Columbus, OH 43240 Phone: 517-599-3778 | |
Dr. Randall E. Harris, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1841 Neil Ave, 306 Cunz Hall, Columbus, OH 43210 Phone: 614-292-4720 Fax: 614-688-3533 | |
Ann Marie Aring, MD Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 697 Thomas Ln, Columbus, OH 43214 Phone: 614-566-5414 Fax: 614-566-6842 | |
Dr. Michael Timothy Kelley, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1166 Dublin Rd, Suite 400, Columbus, OH 43215 Phone: 614-544-4605 |